Newsletter | October 14, 2026

10.14.26 -- FDA Modernizes Container Closure Guidance: What Is Changing And Why It Matters

SPONSOR

Webinar: Advancing drug product manufacturing with a risk-based approach to single-use system integrity

Single-use systems are widely used in biopharmaceutical manufacturing, but expectations for system integrity continue to evolve. This session explores key control points across the SUS lifecycle and how a holistic approach can strengthen contamination control strategies. Learn how clear requirements, regulatory awareness, and effective integrity strategies can support compliance, operational efficiency, and product quality. Click here to learn more.

FOCUS ON FILL-FINISH

FDA Modernizes Container Closure Guidance: What Is Changing And Why It Matters

The proposed revision reflects changes in packaging technology, drug delivery systems, quality risk management, and more that have occurred since 1999's guidance.

Cartridge Filling: Where Precision, Process Control, And Experience Matter

Cartridge drug delivery demands strict controls to guarantee dose accuracy. Early development and testing eliminate variability, prevent defects, and protect patient safety.

Overcoming Challenges In For Scalable Fill-Finish Manufacturing

To meet immediate vaccine demand, aseptic manufacturing capacity must increase quickly. This means environmental monitoring programs must adapt rapidly as well. Thoughtful planning can help.

Weld Integrity And Compatibility In Aseptic Processing

Discover how tubing durability, weld integrity, and system compatibility contribute to reliable aseptic processing and operational efficiency.

Start Packaging Development Early: De-Risk Before You Build

When packaging development follows fill/finish line selection rather than informing it, teams face avoidable retrofits and delays. This article examines why earlier alignment changes outcomes.

FILL-FINISH SOLUTIONS

•

Small Volume Bio-Container Systems - Charter Medical

•

Commercial Autoinjectors: Simplified Packaging Solutions - Thermo Fisher Scientific

•

Integrated Fill‑Finish Capabilities - Novartis Contract Manufacturing

SPONSOR

Bio-Expo Live Downstream Manufacturing Session is a virtual event for biopharma professionals focused on downstream manufacturing solutions. Attendees can discover new equipment and technologies supporting therapeutic areas from ADCs to vaccines through short, interactive presentations with live Q&A. The event is tailored for biopharma companies and contract manufacturers seeking solutions to overcome downstream manufacturing challenges. Register now to reserve your spot!

FOCUS ON DOWNSTREAM MANUFACTURING

Accelerating Technology Transfer Of A Drug Product

See how structured testing can reduce transfer risk, confirm scalability and reuse strategies, as well as how to improve process robustness and deliver meaningful savings on chemicals and consumables.

Chromatography Resins In Therapeutic Treatment Delivery

Explore how chromatography resins are evolving from purification tools to therapeutic agents in cancer treatment, with insights into their chemical properties and clinical potential.

Durability Of Membrane-Based Protein Capture Device With Protein A

Examine how repeated caustic sanitization affected yield, impurity clearance, and microbial control across 100 protein-capture cycles, providing practical evidence for evaluating device durability.

Rethinking Column Care: Why Resin Preservation Is A Lifecycle Strategy

Chromatography resin is expensive, making proper maintenance vital. A cleaning, regeneration, and storage program protects resin longevity, reduces risks, and ensures cost-effective manufacturing.

From Bottlenecks To Breakthroughs: Mastering Buffer Management

Traditional process liquid and buffer manufacturing has been shown to be resource-intensive. Watch to uncover strategies to overcome buffer-related bottlenecks in large-scale biomanufacturing.

The Fundamentals Of Ion Exchange Chromatography

Delve into how protein charge, pH, buffer selection, and resin chemistry influence purification performance, and gain practical insights into process development and optimization.

An Integrated Analytical Approach To Lipase Risk Management

Conventional HCP testing cannot confirm whether residual lipases remain enzymatically active. Here, the authors take a look at why functional activity data are essential for managing stability risk.

DOWNSTREAM MANUFACTURING SOLUTIONS

•

Expanded Series Of Connectors For Even More Versatility - CPC Biotech

•

Pre-Use Post Sterilization Integrity Testing (PUPSIT) Overview - Cytiva

Connect With Bioprocess Online: